Claims
- 1. A compound of Formula (1.0.0): and pharmaceutically acceptable salts and other prodrug derivatives thereof, wherein:A is phenyl, substituted with 0 to 3 R10; or is a member selected from the group consisting of —A1—NHC(═O)NH—A2—, —A1—NHC(═O)O—A2—, and —A1—NH(NCN)NH—A2—, where A1 and A2 is each independently selected from the group consisting of hydrogen, provided that A1 and A2 may not both be hydrogen, and phenyl substituted wish 0 to 3 R10; B is a member independently selected from the group consisting of the following: where the symbol “*” indicates the point of attachment of the moiety represented by each partial Formula (1.1.0) through (1.1.12) to the moiety “Y” in Formula (1.0.0); and the symbol “→” indicates the point of attachment of the moiety represented by each partial Formula (1.1.0) through (1.1.12) to the moiety “E” in Formula (1.0.0); E is a single bond; —O—; —CH═CH—; or a moiety of Formula (1.9.0): where R1a is hydrogen when R1 has the meaning of a mono-valent substituent; and R1a is a single bond when R1 has the meaning of a di-valent substituent; X is —O—; —S(═O)q—; or —N(R14)—; Y is —C(═O)—; —C(═S)—; —S(═O)2—; or —CH(Ra)—; m is an integer independently selected from 0, 1 and 2; n is an integer independently selected from 1 and 2; p is an integer independently selected from 1 and 2, provided that p must be selected as 1 where B is selected as partial Formula (1.1.2), (1.1.3), (1.1.5); (1.1.6), (1.1.7), (1.1.8), (1.1.9), (1.1.10), (1.1.11), or (1.1.12); q is an integer independently selected from 0 and 2; R is independently selected from the group consisting of -tetrazolyl; —C(═O)OR5; —C(═O)(CH2)kC(═O)OR5; —C(═O)NO.; —C(═O)NH—S(═O)2R5; —S(═O)2—NR14R5; —C(═O)NHS(═O)2R6; and a moiety of partial Formulas (3.0.0): where:k is an integer independently selected from 0, 1 and 2; R1 is independently selected from the group consisting of hydrogen; ═O; ═S; F; (C1-C6) alkyl substituted with 0 to 3 R10; (C2-C6) alkenyl substituted with 0 to 3 R10; (C2—C6) alkynyl substituted with 0 to 3 R10; a (C3—C14) carbocyclic ring system substituted with 0 to 3 R12; aryl substituted with 0 to 3 R12; and aryl(C1-C1) alkyl wherein said aryl and alkyl are substituted with 0 to 3 R12; heterocyclyl as defined herein, substituted with 0 to 3 R12; and heterocyclyl(C1-C1) alkyl as defined herein, wherein said heterocyclyl and alkyl are substituted with 0 to 3 R12; C(═O)NR8R9; and C(═O)R8; R2 and R3 are each independently selected from the group consisting of hydrogen; (C1-C1) alkyl substituted with 0 to 3 R13; (C2—C6) alkenyl substituted with 0 to 3 R13; a (C3—C14) carbocyclic ring system substituted with 0 to 3 R13; (C1-C1) alkoxycarbonylamino-(C1-C1)alkyl-; (C1-C1)alkylthio-(C1-C1)alkyl-; (C1-C1) alkylsulfonyl-(C1-C1)alkyl-; hydroxy(C1-C1) alkylthio-(C1-C1)alkyl-; (C1-C1) alkylcarbonylamino-(C1-C1)alkyl-; (C1-C4) alkylsulfonylamino-(C1-C4) alkyl-; (C1-C1) alkylsulfonylaminocarbonyl-(C1-C1) alkyl-; and a heterocyclyl ring as defined herein, substituted with 0 to 3 R13; provided thatR2 and R3 are each defined as above; or they are taken together as defined below; or one of them is taken together with R4 as defined below, in which case the other has the meaning of hydrogen or methyl; R2 and R3 are taken together to form a spirocyclic (C3-C14) carbocyclic ring substituted with 0 to 3 R13; or R2 or R3 is taken together with R4 and the carbon and nitrogen atoms to which they are respectively attached to form a heteroaryl or heterocyclyl group as defined herein, substituted with 0 to 3 R12; R5 is hydrogen; (C1-C1) alkyl; (C3-C6) cycloalkyl; or aryl; R6 is hydrogen; (C1-C1) alkyl; (CH2)r—(C3-C6)cycloalkyl; or (CH2)s-aryl; where: r and s are each independently an integer selected from 0, 1, and 2; R8 and R9 are each independently selected from the group consisting of hydrogen; (C1-C1) alkyl substituted with 0 to 3 R10; a (C3-C14) carbocyclic ring system substituted with 0 to 3 R12; aryl substituted with 0 to 3 R12; and aryl-(C1-C1) alkyl wherein said aryl and alkyl are substituted with 0 to 3 R12; heterocyclyl as defined herein, substituted with 0 to 3 R12; and heterocyclyl-(C1-C4) alkyl as defined herein, wherein said heterocyclyl and alkyl are substituted with 0 to 3 R12; R10 is independently selected from the group consisting of F; Cl; —C(═O)OR14; —OH; nitro; cyano; amino; di(C1-C1) alkylamino; (C1-C1) alkyl; (C1-C4) alkoxy; (C1-C4) alkylthio; and (C1-C1) alkyl and (C1-C1) alkoxy each substituted with 1 to 3 substituents independently selected from F and Cl; R12 when a substituent on a carbon atom, is independently selected from the group consisting of F; Cl; (C1-C1) alkyl; (C3-C6) cycloalkyl; (C1-C4) alkoxy; —C(═O)OR14; —OH; (C1-C1) alkyl and (C1-C1) alkoxy each substituted with 1 to 3 substituents independently selected from F and Cl; or R12 when R12 is attached to a saturated carbon atom, may be ═O or ═S; or when R12 is attached to a sulfur atom, may be ═O; R12 when a substituent on a nitrogen atom, is independently selected from the group consisting of hydroxy; hydroxy(C1-C1) alkyl; (C1-C1) alkoxy; (C3-C6) cycloalkyl; (C1-C4) alkylcarbonyl; and phenyl R13 is (C1-C1) alkoxy; and R14 is hydrogen; hydroxy; (C1-C1) alkyl; (C3-C6) cycloalkyl; or aryl.
- 2. A compound according to claim 1 wherein A is selected from the group consisting of —A1—NHC(═O)NH—A2—, —A1—NHC(═O)O—A2—, and —A1—NH(NCN)NH—A2—, where A1 and A2 is each independently selected from the group consisting of hydrogen, provided that A1 and A2 may not both be hydrogen, and phenyl substituted with 0 or 1 substituent R10.
- 3. A compound according to claim 2 wherein R10 is a member selected from the group consisting of F, Cl, F3C—, methyl, methoxy, hydroxyl, and iso-propyl.
- 4. A compound according to claim 3 wherein n is the integer 1 resulting in a methylene bridge.
- 5. A compound according to claim 4 wherein said component A and said methylene bridge attached thereto comprise a member selected from the group consisting of 4-hydroxyphenyl-; 3-methoxy4-(N′-phenylurea)-phenylmethyl-; 4-(N′-phenylurea)-phenylmethyl-; 4-(N′-(2-methylphenyl)urea)phenylmethyl-; 4-(N′-(2-methoxyphenyl)urea)-phenylmethyl-; 3-methoxy-4-(N′-(2-methylphenyl)urea)-phenylmethyl-; 4-(N′-(2-pyridyl)urea)-phenylmethyl-; 4-(N′-(2-fluorophenyl)urea)phenylmethyl-; 4-(N′-(2-chlorophenyl)urea)-phenylmethyl-; 4-(N′-(2-chlorophenyl)urea)-3-methoxyphenylmethyl-; 4-(N′-(4-iso-propylphenyl)urea)-phenylmethyl-; and 4-(N′-(2-cyclopentyl)urea)phenylmethyl-.
- 6. A compound according to claim 3 wherein Y is —C(═O)—.
- 7. A compound according to claim 6 wherein B is a member selected from the group consisting of partial Formulas (1.1.2) and (1.1.6): where the symbol “*” and the symbol “→” are as previously defined; and wherein X is oxygen, sulfur or nitrogen.
- 8. A compound according to claim 7 wherein one of R2 and R3 is hydrogen and the other is selected from the group consisting essentially of iso-propyl, sec-butyl, iso-butyl, and tert-butyl; E- and Z-iso-butenyl, and E- and Z-pentenyl; cyclopentyl and cyclohexyl; cyclohexenyl, and cyclopentadienyl; phenyl, indenyl and indanyl; 2-(methyithio)ethyl; 3-(hydroxypropylthio)methyl; 2-(methylsulfonyl)ethyl; 4-(acetylamino)butyl; 4-(methylsulfonylamino)butyl; and 4-ethoxycarbonylamino)butyl.
- 9. A compound according to claim 7 wherein p is 1; m is 1 or 2; and E is a bridging moiety of partial Formula (1.9.0): where R1a is hydrogen when R1 has the meaning of a mono-valent substituent; and R1a is a single bond when R1 has the meaning of a di-valent substituent; and wherein R1 is a member selected from the group consisting essentially of methyl; ethyl; iso-propyl; tert-butyl; 2-propenyl; 1-, 2-, or 3-butenyl; ethynyl; propargyl; cyclopropyl; cyclopentyl; phenyl; phenylmethyl; phenylethyl; and heterocyclyl.
- 10. A compound according to claim 9 wherein R1 is independently substituted by 1 or 2 substituents R12.
- 11. A compound according to claim 9 wherein R1 is heterocyclyl substituted with 1 or 2 R12; or heterocyclyl(C1-C1)alkyl wherein said heterocyclyl and alkyl are substituted with 1 or 2 R12.
- 12. A compound according to claim 7 wherein R1 is 1,3-benzodioxol-5-yl; 3,4-dimethoxyphenyl; 3,4-difluorophenyl; or benzo-1,4-dioxanyl; respectively of partial Formulas (1.2.1), (1.2.2), (1.2.3), and (1.2.4):
- 13. A compound according to claim 7 wherein R is COOH.
- 14. A compound according to claim 1 wherein said compound is:3-[2-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-oxazol-5-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[4-(3-{2-fluorophenyl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-oxazol-5-yl]-propionic acid; 2-[2-(3-Methyl-1-{2-[4-(3-{2-cyclopentylphenyl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-oxazol-5-yl]-acetic acid; 4-[2-(3-Methyl-1-{2-[4-(3-{3-methylpyridin-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-oxazol-5-yl]-butyric acid; 3-[2-(3-Methyl-1-{2-[4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-oxazol-5-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[3-methoxy-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-oxazol-5-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[3-methyl-4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-thiazol-5-yl]-propionic acid; 2-[2-(3-Methyl-1-{2-[3-fluoro-4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-thiazol-5-yl]-acetic acid; 3-[2-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1,1-dioxo-4,5-dihydro-thiazol-5-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[3-methyl-4-(3-{3-methylpyridin-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-imidazol-5-yl]-propionic acid; 4-[2-(3-Methyl-1-{2-[3-fluoro-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5dihydro-imidazol-5-yl]-butyric acid; 3-[2-(3-Methyl-1-{2-[3-methyl-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-imidazol-5-yl]-propionic acid; 2-[2-(3-Methyl-1-{2-[3-fluoro-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5dihydro-imidazol-5-yl]-acetic acid; 3-{2-[1-(2-{4-[3-(2-Chloro-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-propionic acid; 3-{2-[1-(2-{4-[3-(2-Methoxy-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-propionic acid; 3-{2-[1-(2-{4-[3-(2-Fluoro-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-propionic acid; 3-{2-[1-(2-{4-[3-(2,6-Dichloro-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-propionic acid; 3-{2-[1-(2-{4-[3-(2,6-Dimethyl-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-propionic acid; 3-{2-[1-(2-{4-[3-(2-Chloro-6-methyl-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-propionic acid; 3-[2-(3-Methyl-1-{2-[4-(3-phenyl-ureido)-phenyl]-acetylamino}-butyl)-thiazol-5-yl]-propionic acid; N-Hydroxy-3-[-2-(3-methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-thiazol-5-yl]-propionamide; 3-[2-(1-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetylamino}-but-3-enyl)-thiazol-5-yl]-propionic acid; 3-[2-(1-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetylamino}-butyl)-thiazol-5-yl]-propionic acid; N-{1-[5-(3-Methanesulfonylamino-3-oxo-propyl)-thiazol-2-yl]-3-methyl-butyl}-2-[4-(3-o-tolyl-ureido)-phenyl]-acetamide; 2-{4-[3-(2-Chloro-phenyl)-ureido]-phenyl}N-{1-[5-(3-methanesulfonylamino-3-oxo-propyl)-thiazol-2-yl]-3-methyl-butyl}-acetamide; 3-[2-({2-[4-(3-o-Tolyl-ureido)-phenyl]-acetylamino}-methyl)-thiazol-5-yl]-propionic acid; 3-{2-[(2-{4-[3-(2-Chloro-phenyl)-ureido]-phenyl}-acetylamino)-methyl]-thiazol-5-yl}-propionic acid; 3-[2-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-oxazol-4-yl]-propionic acid; 4-[2-(3-Methyl-1-{2-[4-{3-(3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-oxazol-4-yl]-butyric acid; 3-[2-(3-Methyl-1-{2-[3-methoxy-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-oxazol-4-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[3-methyl-4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-thiazol-4-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1,1-dioxo-4,5-dihydro-thiazol-4yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[3-methyl-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-imidazol-4-yl]-propionic acid; 2-[2-(3-Methyl-1-{2-[3-fluoro-4-(3-{3-cyopentylpyrid-2-yl)-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-imidazol-4-yl]-acetic acid; 3-[2-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-oxazol-5-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-oxazol-5-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[4-(3-{2-methoxyphenyl}-ureido)-phenyl]-acetylamino}-butyl)-oxazol-5-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-oxazol-5-yl]-propionic acid; 4-[2-(3-Methyl-1-{2-[4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-oxazol-5-yl]-butyric acid; 2-[2-(3-Methyl-1-{2-[3-methyl-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-oxazol-5-yl]-acetic acid; 3-[2-(3-Methyl-1-{2-[3-fluoro-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-oxazol-5-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[3-methoxy-4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl-thiazol-5-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[3-methyl-4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1,1-dioxo-thiazol-5-yl]-propionic acid; 4-[2-(3-Methyl-1-{2-[3-fluoro-4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-thiazol-5-yl]-butyric acid; 3-[2-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-5-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[3-cyclopentyl-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-5-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-5-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[3-trifluoromethyl-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-5-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-oxazol-4-yl]-propionic acid; 4-[2-(3-Methyl-1-{2-[4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-oxazol-4-yl]-butyric acid; 3-[2-(3-Methyl-1-{2-[3-methoxy-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-oxazol-4-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[3-methyl-4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-thiazol-4-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1,1-dioxo-thiazol-4-yl]-propionic acid; 3-[2-(3-Methyl-1-{2-[3-methyl-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-4-yl]-propionic acid; 2-[2-(3-Methyl-1-{2-[3-fluoro-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-4-yl]-acetic acid; 3-[3-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-isoxazol-5-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[4-(3-{2-fluorophenyl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-isoxazol-5-yl]-propionic acid; 2-[3-(3-Methyl-1-{2-[4-(3-{2-cyclopentylphenyl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-isoxazol-5-yl]-acetic acid; 4-[3-(3-Methyl-1-{2-[4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-isoxazol-5-yl]-butyric acid; 3-[3-(3-Methyl-1-{2-[4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-isoxazol-5-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[3-methoxy-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-isoxazol-5-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-pyrazol-1-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[4-(3-{2-methoxyphenyl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-pyrazol-1-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-pyrazol-1-yl]-propionic acid; 4-[3-(3-Methyl-1-{2-[4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-pyrazol-1-yl]-butyric acid; 2-[3-(3-Methyl-1-{2-[3-methyl-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-pyrazol-1-yl]-acetic acid; 3-[3-(3-Methyl-1-{2-[3-fluoro-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-pyrazol-1-yl]-acid; 3-[3-(3-Methyl-1-{2-[3-methoxy-4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-pyrazol-1-yl]-propionic acid; 4-[3-(3-Methyl-1-{2-[3-fluoro-4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-pyrazol-1-yl]-butyric acid; 3-[3-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-pyrazol-1-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[3-cyclopentyl-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-pyrazol-1-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-pyrazol-1-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[3-trifluoromethyl-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-4,5-dihydro-pyrazol-1-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-isoxazol-5-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[4-(3-{2-fluorophenyl}-ureido)-phenyl]-acetylamino}-butyl)-isoxazol-5-yl]-propionic acid; 2-[3-(3-Methyl-1-{2-[4-(3-{2-cyclopentylphenyl}-ureido)-phenyl]-acetylamino}-butyl)-isoxazol-5-yl]-acetic acid; 4-[3-(3-Methyl-1-{2-[4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-isoxazol-5-yl]-butyric acid; 3-[3-(3-Methyl-1-{2-[4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-isoxazol-5-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[3-methoxy-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-isoxazol-5-yl]-propionic acid; 3-{3-[3-Methyl-1-(2-{4-[3-(4-methyl-pyridin-3-yl)-ureido]-phenyl}-acetylamino)-butyl]-isoxazol-5-yl}-propionic acid; 3-[3-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-isoxazol-5-yl]-acrylic acid; 3-{3-[1-(2-{4-[3-(2-Chloro-phenyl)-ureido]-pheny}-acetylamino)-3-methyl-butyl]-isoxazol-5-yl}-propionic acid; 3-{3-[1-(2-{4-[3-(2-Chloro-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-isoxazol-5-yl}-3-oxo-propionic acid ethyl ester; 3-[3-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-pyrazol-1-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[4-(3-{2-methoxyphenyl}-ureido)-phenyl]-acetylamino}-butyl)-pyrazol-1-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-pyrazol-1-yl]-propionic acid; 4-[3-(3-Methyl-1-{2-[4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-pyrazol-1-yl]-butyric acid; 2-[3-(3-Methyl-1-{2-[3-methyl-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-pyrazol-1-yl]-acetic acid; 3-[3-(3-Methyl-1-{2-[3-fluoro-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-pyrazol-1-yl]-acid; 3-[3-(3-Methyl-1-{2-[3-methoxy-4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-pyrazol-1-yl]-propionic acid; 4-[3-(3-Methyl-1-{2-[3-fluoro-4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-pyrazol-1-yl]-butyric acid; 3-[3-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-pyrazol-1-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[3-cyclopentyl-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-pyrazol-1-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-pyrazol-1-yl]propionic acid; 3-[3-(3-Methyl-1-{2-[3-trifluoromethyl-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]acetylamino}-butyl)-pyrazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-oxazol-2-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-oxazol-2-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[4-(3-{2-methoxyphenyl}-ureido)-phenyl]-acetylamino}-butyl)-oxazol-2-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-oxazol-2-yl]-propionic acid; 4-[4-(3-Methyl-1-{2-[4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-oxazol-2-yl]-butyric acid; 2-[4-(3-Methyl-1-{2-[3-methyl-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-oxazol-2-yl]-acetic acid; 3-[4-(3-Methyl-1-{2-[3-fluoro-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-oxazol-2-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[3-methoxy-4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-thiazol-2-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[3-methyl-4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1,1-dioxo-thiazol-2-yl]-propionic acid; 4-[4-(3-Methyl-1-{2-[3-fluoro-4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-thiazol-2-yl]-butyric acid; 3-[4-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-2-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[3-cyclopentyl-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-2-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-2-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[3-trifluoromethyl-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-2-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-imidazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[4-(3-{2-methoxyphenyl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-1-yl]-propionic acid; 4-[4-(3-Methyl-1-{2-[4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-1-yl]-butyric acid; 2-[4-(3-Methyl-1-{2-[3-methyl-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-imidazol-1-yl]-acetic acid; 3-[4-(3-Methyl-1-{2-[3-fluoro-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-imidazol-1-yl]-acid; 3-[4-(3-Methyl-1-{2-[3-methoxy-4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-1-yl]-propionic acid; 4-[4-(3-Methyl-1-{2-[3-fluoro-4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-1-yl]-butyric acid; 3-[4-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[3-cyclopentyl-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-1-yl]-propionic acid; 3-4-(3-Methyl-1-{2-[3-trifluoromethyl-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-imidazol-1-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-1,2,4-oxadiazol-5-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[4-(3-{2-fluorophenyl}-ureido)-phenyl]-acetylamino}-butyl)-1,2,4-oxadiazol-5-yl]-propionic acid; 2-[3-(3-Methyl-1-{2-[4-(3-{2-cyclopentylphenyl}-ureido)-phenyl]-acetylamino}-butyl)-1,2,4-oxadiazol-5-yl]-acetic acid; 4-[3-(3-Methyl-1-{2-[4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1,2,4-oxadiazol-5-yl]-butyric acid; 3-[3-(3-Methyl-1-{2-[4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1,2,4-oxadiazol-5-yl]-propionic acid; 3-[3-(3-Methyl-1-{2-[3-methoxy-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-4,5-1,2,4-oxadiazol-5-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,4-triazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[4-(3-{2-methoxyphenyl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,4-triazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,4-triazol-1-yl]-propionic acid; 4-[4-(3-Methyl-1-{2-[4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,4-triazol-1-yl]-butyric acid; 2-[4-(3-Methyl-1-{2-[3-methyl-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,4-triazol-1-yl]-acetic acid; 3-[4-(3-Methyl-1-{2-[3-fluoro-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,4-triazol-1-yl]-acid; 3-[4-(3-Methyl-1-{2-[3-methoxy-4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,4-triazol-1-yl]-propionic acid; 4-[4-(3-Methyl-1-{2-[3-fluoro-4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,4-triazol-1-yl]-butyric acid; 3-[4-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,4-triazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[3-cyclopentyl-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,4-triazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,4-triazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[3-trifluoromethyl-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,4-triazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,3,4-tetrazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[4-(3-{2-methoxyphenyl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,3,4-tetrazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,3,4-tetrazol-1-yl]-propionic acid; 4-[4-(3-Methyl-1-2-[4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,3,4-tetrazol-1-yl]-butyric acid; 2-[4-(3-Methyl-1-{2-[3-methyl-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,3,4-tetrazol-1-yl]-acetic acid; 3-[4-(3-Methyl-1-{2-[3-fluoro-4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,3,4-tetrazol-1-yl]-acid; 3-[4-(3-Methyl-1-{2-[3-methoxy-4-(3{-pyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,3,4-tetrazol-1-yl]-propionic acid; 4-[4-(3-Methyl-1-{2-[3-fluoro-4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,3,4-tetrazol-1-yl]-butyric acid; 3-[4-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,3,4-tetrazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[3-cyclopentyl-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,3,4-tetrazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[3-methoxy-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,3,4-tetrazol-1-yl]-propionic acid; 3-[4-(3-Methyl-1-{2-[3-trifluoromethyl-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-butyl)-1H-1,2,3,4-tetrazol-1-yl]-propionic acid; 3-(3-iso-butyl-2-oxo-4-{[4-(3-o-tolylureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 3-(3-iso-butyl-2-oxo-4-{[4-(3-{2-methoxyphenyl}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 3-(3-iso-butyl-2-oxo-4-{[4-(3-{pyrid-2-y}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 4-(3-iso-butyl-2-oxo-4-{[4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-butyric acid; 2-(3-iso-butyl-2-oxo-4-{[3-methyl-4-(3-o-tolyl-ureido)-phenyl]-acetyl}-piperazin-1-yl)-acetic acid; 3-(3-iso-butyl-2-oxo-4-{[3-fluoro-4-(3-o-tolyl-ureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 3-(3-iso-butyl-2-oxo-4-{[3-methoxy-4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 4-(3-iso-butyl-2-oxo-4-{[3-fluoro-4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-butyric acid; 3-(3-iso-butyl-2-oxo-4-{[3-methoxy-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 3-(3-iso-butyl-2-oxo-4-{[3-cyclopentyl-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 3-(3-iso-butyl-2-oxo-4-{[3-methoxy-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-piperazin-1-yl)-propionic acid; 3-(3-iso-butyl-2-oxo-4-{[3-trifluoromethyl-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 3-(3-iso-butyl-6-oxo-4-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 3-(3-iso-butyl-6-oxo-4-{4-(3-{2-methoxyphenyl}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 3-(3-iso-butyl-6-oxo-4-{[4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 4-(3-iso-butyl-6-oxo-4-{[4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-butyric acid; 2-(3-iso-butyl-6-oxo-4-{[3-methyl-4-(3-o-tolyl-ureido)-phenyl]-acetyl}-piperazin-1-yl)-acetic acid; 3-(3-iso-butyl-6-oxo-4-{[3-fluoro-4-(3-o-tolyl-ureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 3-(3-iso-butyl-6-oxo-4-{[3-methoxy-4-(3-{pyrid-2-yl}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 4-(3-iso-butyl-6-oxo-4-{[3-fluoro-4-(3-{3-methoxypyrid-2-yl}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-butyric acid; 3-(3-iso-butyl-6-oxo-4-{[3-methoxy-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 3-(3-iso-butyl-6-oxo-4-{[3-cyclopentyl-4-(3-{3-methylpyrid-2-yl}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 3-(3-iso-butyl-6-oxo-4-{[3-methoxy-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetylamino}-piperazin-1-yl)-propionic acid; 3-(3-iso-butyl-6-oxo-4-{[3-trifluoromethyl-4-(3-{3-cyclopentylpyrid-2-yl}-ureido)-phenyl]-acetyl}-piperazin-1-yl)-propionic acid; 3-{2-[1-(2-{4-[3-(2-Chloro-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-propionic acid; 3-{2-[1-(2-{4-[3-(2,6-Dichloro-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-propionic acid; 3-{2-[1-(2-{4-[3-(2-Fluoro-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-propionic acid; 3-[2-(1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-3-methyl-butyl)-thiazol-5-yl]-propionic acid; 3-{2-[1-(2-{4-[3-(2-Dimethyl-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-propionic acid; 3-{2-[1-(2-{4-[3-(2-Chloro-6-methyl-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-propionic acid; 3-{2-[1-(2-{4-[3-(2-Methoxy-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-propionic acid; 3-{2-[1-(2-{4-[3-(Phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-propionic acid; 3-[2-(1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-3-butenyl)-thiazol-5-yl]-propionic acid; 3-{2-[1-(2-{4-[3-(2-Methyl-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-prop-2-enoic acid; 3-{2-[1-(2-{4-[3-(2-Methyl-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-1-hydroximino-propionic acid; 3-{2-[1-(2-{4-[3-(2-Methyl-phenyl)-ureido]-phenyl}-acetylamino)-n-butyl]-thiazol-5-yl}-propionic acid; 3-{2-[1-(2-{4-[3-(2-Methyl-phenyl)-ureido]-phenyl}-acetylamino)-3-methyl-butyl]-thiazol-5-yl}-1-methylsulfonyl-propionamide; 3-[3-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-isoxazol-5-yl]-2-oxo-propionic acid ethyl ester; 3-[3-(3-Methyl-1-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-butyl)-isoxazol-5-yl]-prop-2-enoic acid; 3-[2-(1-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-(5-Methyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-(5,5-Dimethyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-(3-Methyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-(3,3-Dimethyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-(4-Methyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-(4-Hydroxy-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-(4-Hydroxy-4-methyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-(1-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-azepan-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-(4-Oxo-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-(4-Amino-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-(4-Methylamino-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-(4-(Ethyl-methyl-amino)-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-(2-Methyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2(3-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-oxazolidin-4-yl)-thiazol-5-yl]-propionic acid; 3-(3′-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-2′,3′,4′,5′-tetrahydro-[2,4′]bithiazolyl-5-yl)-propionic acid; 3-[2-(1-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-1,2,3,6-tetrahydro-pyridin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-(1-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-piperidin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-(2-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-1,2,3,4-tetrahydro-isoquinolin-3-yl)-thiazol-5-yl]-propionic acid; 3-[2-(1-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-azetidin-2-yl)-thiazol-5-yl]-propionic acid; 3-[2-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-azetidin-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(1-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(1-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-azepan-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(5-Methyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(5,5-Dimethyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(3-Methyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(3,3-Dimethyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(4-Methyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)oxazol-5-yl]-propionic acid; 3-[2-(4-Hydroxy-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(4-Hydroxy-4-methyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(4-Oxo-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(4-Amino-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(4-Methylamino-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(4-(Ethyl-methyl-amino)-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(2-Methyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(3-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-oxazolidin-4-yl)oxazol-5-yl]-propionic acid; 3-[2-(3-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-thiazolidin-4-yl)-oxazol-5-yl]-propionic acid; 3-[2-(1-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-1,2,3,6-tetrahydro-pyridin-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(1-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-piperidin-2-yl)-oxazol-5-yl]-propionic acid; 3-[2-(2-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-1,2,3,4-tetrahydro-isoquinolin-3-yl)-oxazol-5-yl]-propionic acid; 3-[3-(1-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(5-Methyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(5,5-Dimethyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(1-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-azepan-2-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(3-Methyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(3,3-Dimethyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(4-Methyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(4-Hydroxy-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(4-Hydroxy-4-methyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-isoxazol-2-yl]-thiazol-5-yl]-propionic acid; 3-[3-(4-Oxo-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(4-Amino-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(4-Methylamino-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(4-(Ethyl-methyl-amino)-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(2-Methyl-1-{[4-(3-o-tolyl-ureido)-phenyl]-acetyl}-pyrrolidin-2-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(3-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-oxazolidin-4-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(3-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-thiazolidin-4-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(1-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-1,2,3,6-tetrahydro-pyridin-2-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(1-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-piperidin-2-yl)-isoxazol-5-yl]-propionic acid; 3-[3-(2-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-1,2,3,4-tetrahydro-isoquinolin-3-yl)-isoxazol-5-yl]-propionic acid; and 3-[3-(1-{[4-(3-o-Tolyl-ureido)-phenyl]-acetyl}-azetidin-2-yl)-isoxazol-5-yl]-propionic acid.
- 15. A pharmaceutical composition comprising a compound of Formula (1.0.0) as defined in claim 1 together with a pharmaceutically acceptable carrier for said compound, wherein the amount of said compound present is effective for inhibiting, suppressing or reducing cell adhesion and consequent or associated pathogenic processes subsequently mediated by VLA-4.
- 16. A pharmaceutical composition according to claim 15 additionally containing therapeutic agent or agents selected from the group consisting essentially of anti-inflammatory corticosteroids; nonsteroidal anti-inflammatory agents; bronchodilators; anti-asthmatic agents; immunosuppressant agents; immunostimulants; antimetabolites; antipsoriatics; and antidiabetics.
- 17. A pharmaceutical composition according to claim 16 wherein said therapeutic agent is a member selected from the group consisting essentially of theophylline, sulfasalazine, aminosalicylates; cyclosporin, FK-506, rapamycin, clophosphamide, methotrexate, and the interferons.
- 18. A method of treating an inflammatory, autoimmune or respiratory diseases by inhibiting cell adhesion and consequent or associated pathogenic processes subsequently mediated by VLA4, comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of Formula (1.0.0) as defined in claim 1 or a pharmaceutical composition as defined in claim 15.
- 19. A method according to claim 18 wherein said inflammatory, autoimmune or respiratory disease is a member selected from the group consisting essentially of asthma, multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, psoriasis, host rejection following organ transplantation, and atherosclerosis.
Parent Case Info
This application claims benefit of Prov. No. 60/091,180 filed Jun. 30, 1998.
Foreign Referenced Citations (1)
Number |
Date |
Country |
2000000477 |
Jan 2000 |
WO |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/091180 |
Jun 1998 |
US |